China CDC Weekly
Articles in Press [Selected]
Notes from the Field: Emerging Variants of B.1.617 Lineage Identified Among Returning Chinese Employees Working in India — Chongqing Municipality, China, April 2021
Technical Vaccination Recommendations for COVID-19 Vaccines in China (First Edition)
Online Date: March 31 2021
National Health Commission of the People’s Republic of China [to 1 May 2021]
May 1: Daily briefing on novel coronavirus cases in China
On April 30, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 16 new cases of confirmed infections.
China continues measures to control imported COVID cases
China will continue to take strict measures to prevent imported COVID-19 infections via people or goods after several inbound travelers tested positive for novel coronavirus after finishing quarantine, a senior health official said on April 29.
Wang Bin, a senior official at the National Health Commission, said the commission requires all inbound travelers to take nucleic acid tests during quarantine.
At the end of the 14-day medical quarantine, they should receive nucleic acid tests from at least two institutions to increase the accuracy of the tests, she said at a news conference.
After they finish the 14-day medical quarantine, they should observe seven-day home health monitoring, take necessary epidemic containment measures when going out and avoid large gatherings, she said…
National Medical Products Administration – PRC [to 1 May 2021]
Vice-premier stresses production, supply of COVID-19 vaccines
Vice-Premier Sun Chunlan on April 29 called for speeding up the production and supply of COVID-19 vaccines, ensuring quality and safety and promoting vaccination among the public to build an immune barrier.
Over 243 million COVID-19 vaccine doses administered across China
More than 243.9 million doses of COVID-19 vaccines had been administered across China as of Wednesday, the National Health Commission said on April 29.
China’s new recombinant COVID-19 vaccine starts human tests
Chinese pharmaceutical giant Sinopharm has commenced phase-1 and phase-2 clinical trials for its new recombinant vaccine against COVID-19 in Central China’s Henan province since April 24.